Taiji Mizoguchi

In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

Kiran Musunuru, Alexandra C. Chadwick, Taiji Mizoguchi et al. · Nature · 2021 · 713 citations

Knockout Mouse, Genetics, Genetic Engineering +8

<i>Bacteroides vulgatus</i> and <i>Bacteroides dorei</i> Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis

Naofumi Yoshida, Takuo Emoto, Tomoya Yamashita et al. · Circulation · 2018 · 597 citations · Full text

Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease

Takuo Emoto, Tomoya Yamashita, Naoto Sasaki et al. · Journal of Atherosclerosis and Thrombosis · 2016 · 307 citations · Full text

Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease

Takuo Emoto, Tomoya Yamashita, Toshio Kobayashi et al. · Heart and Vessels · 2016 · 172 citations

Probiotic, Dysbiosis, Molecular Epidemiology +11

Gut Microbiome and Plasma Microbiome-Related Metabolites in Patients With Decompensated and Compensated Heart Failure

Tomohiro Hayashi, Tomoya Yamashita, Hikaru Watanabe et al. · Circulation Journal · 2018 · 127 citations · Full text